Kshipra Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -6.38%
(FY 2023)
- Profit 9.16%
(FY 2023)
- Ebitda -292.33%
(FY 2023)
- Net Worth 51.03%
(FY 2023)
- Total Assets -12.84%
(FY 2023)
About Kshipra Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pawan Dubey, Pankaj Dubey, and Deepika Dubey serve as directors at the Company.
- CIN/LLPIN
U24100MP2015PTC033823
- Company No.
033823
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Dewas, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kshipra Biotech Private Limited offer?
Kshipra Biotech Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Fruit Extracts, Essential & Aromatic Oils, Essential Oils, Pharma Ingredients & Raw Materials, Anti Infective API, Herbal Extracts, Ayurvedic Powder and Medicinal Herbs, Herb Leaves, Spices Extracts.
Who are the key members and board of directors at Kshipra Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pawan Dubey  | Director | 11-Feb-2015 | Current |
| Pankaj Dubey | Director | 11-Feb-2015 | Current |
| Deepika Dubey | Director | 03-Sep-2021 | Current |
Financial Performance of Kshipra Biotech.
Kshipra Biotech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.38% decrease. The company also saw a slight improvement in profitability, with a 9.16% increase in profit. The company's net worth Soared by an impressive increase of 51.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kshipra Biotech?
In 2023, Kshipra Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kshipra Biotech?
Unlock and access historical data on people associated with Kshipra Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kshipra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kshipra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
